Multiple Sclerosis Therapeutics Market Size And Share

  • Report Code : TIPRE00004057
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 169
Buy Now

Multiple Sclerosis Therapeutics Market Size, Share, and Forecast by 2027

Buy Now

Multiple Sclerosis Therapeutics Market Report Multiple Sclerosis Therapeutics Market Scope and Analysis Multiple Sclerosis Therapeutics Market Size and Share

Multiple Sclerosis Therapeutics Market: Strategic Insights

Multiple Sclerosis Therapeutics Market

  • CAGR (2019 - 2027)
    6.5%
  • Market Size 2019
    US$ 24.03 Billion
  • Market Size 2027
    US$ 39.22 Billion

Market Dynamics

GROWTH DRIVERS
  • Increase in multiple sclerosis diagnosis
  • Rising demand for effective MS therapeutics
FUTURE TRENDS
  • Personalized therapies for multiple sclerosis
  • Rise in biologic drug usage for MS treatment
OPPORTUNITIES
  • Expansion in neurodegenerative disease therapeutics
  • Rising opportunities in MS drug development

Key Players

  • Merck Co Inc
  • Novartis AG
  • Bayer AG
  • Sanofi
  • Bristol Myers Squibb Company
  • Horizon Therapeutics plc
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Takeda Pharmaceutical Company Limited
  • F HOFFMANN LA ROCHE LTD

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Drug Class
  • Immunosuppressant and Immunomodulators
Route of Administration
  • Injectable and Oral
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce